219 related articles for article (PubMed ID: 35693129)
1. Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review.
Sileshi T; Mekonen G; Makonnen E; Aklillu E
Pharmgenomics Pers Med; 2022; 15():561-571. PubMed ID: 35693129
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of drug-drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management.
MacDougall C; Canonica T; Keh C; P Phan BA; Louie J
Pharmacotherapy; 2022 Apr; 42(4):343-361. PubMed ID: 35152432
[TBL] [Abstract][Full Text] [Related]
3. Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis.
Weiner M; Gelfond J; Johnson-Pais TL; Engle M; Johnson JL; Whitworth WC; Bliven-Sizemore E; Nsubuga P; Dorman SE; Savic R;
J Antimicrob Chemother; 2021 Feb; 76(3):582-586. PubMed ID: 33374006
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine.
Francis J; Zvada SP; Denti P; Hatherill M; Charalambous S; Mungofa S; Dawson R; Dorman S; Gupte N; Wiesner L; Jindani A; Harrison TS; Olagunju A; Egan D; Owen A; McIlleron HM
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670438
[TBL] [Abstract][Full Text] [Related]
6. Influence of Single Nucleotide Polymorphisms on Rifampin Pharmacokinetics in Tuberculosis Patients.
Thomas L; Sekhar Miraj S; Surulivelrajan M; Varma M; Sanju CSV; Rao M
Antibiotics (Basel); 2020 Jun; 9(6):. PubMed ID: 32521634
[TBL] [Abstract][Full Text] [Related]
7. Drug-drug Interactions of Angiotensin Converting Enzyme Inhibitors Mediated by Metabolizing Enzymes and Transporters.
Sun P; Liu K
Curr Drug Metab; 2018; 19(13):1119-1129. PubMed ID: 30062958
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of concomitant rifamycin and opioid therapy: A systematic review.
Kinney EM; Vijapurapu S; Covvey JR; Nemecek BD
Pharmacotherapy; 2021 May; 41(5):479-489. PubMed ID: 33748959
[TBL] [Abstract][Full Text] [Related]
9. Variability in plasma rifampicin concentrations and role of
Sileshi T; Makonnen E; Telele NF; Barclay V; Zumla A; Aklillu E
Infect Dis (Lond); 2024 Apr; 56(4):308-319. PubMed ID: 38315168
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline.
Zubiaur P; Matas M; Martín-Vílchez S; Soria-Chacartegui P; Villapalos-García G; Figueiredo-Tor L; Calleja S; Navares-Gómez M; de Miguel A; Novalbos J; Mejía-Abril G; Luquero-Bueno S; Román M; Ochoa D; Abad-Santos F
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297437
[TBL] [Abstract][Full Text] [Related]
11. SLCO1B1 and SLC10A1 polymorphism and plasma rifampin concentrations in patients with co-morbidity tuberculosis-diabetes mellitus in Baja California, Mexico.
Perea-Jacobo R; Muñiz-Salazar R; Laniado-Laborín R; Zenteno-Cuevas R; Cabello-Pasini A; Ochoa-Terán A; Radilla-Chávez P
Tuberculosis (Edinb); 2022 Sep; 136():102248. PubMed ID: 36055153
[TBL] [Abstract][Full Text] [Related]
12. Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine.
Nakajima A; Fukami T; Kobayashi Y; Watanabe A; Nakajima M; Yokoi T
Biochem Pharmacol; 2011 Dec; 82(11):1747-56. PubMed ID: 21856291
[TBL] [Abstract][Full Text] [Related]
13. Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition.
Ni W; Ji J; Dai Z; Papp A; Johnson AJ; Ahn S; Farley KL; Lin TS; Dalton JT; Li X; Jarjoura D; Byrd JC; Sadee W; Grever MR; Phelps MA
PLoS One; 2010 Nov; 5(11):e13792. PubMed ID: 21072184
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis.
Rabie H; Decloedt EH; Garcia-Prats AJ; Cotton MF; Frigati L; Lallemant M; Hesseling A; Schaaf HS
Expert Opin Pharmacother; 2017 Apr; 18(6):589-598. PubMed ID: 28346018
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
Bosch TM
Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
[TBL] [Abstract][Full Text] [Related]
16. Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes.
Yoo HD; Lee YB
Arch Pharm Res; 2011 Nov; 34(11):1817-28. PubMed ID: 22139683
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy.
Li J; Bluth MH
Pharmgenomics Pers Med; 2011; 4():11-33. PubMed ID: 23226051
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacogenetics and potential application in personalized medicine.
Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
[TBL] [Abstract][Full Text] [Related]
19. Association of genetic polymorphisms of
Yang S; Hwang SJ; Park JY; Chung EK; Lee JI
BMJ Open; 2019 Aug; 9(8):e027940. PubMed ID: 31375612
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanisms.
Hirota T; Takane H; Higuchi S; Ieiri I
Curr Drug Metab; 2008 Jan; 9(1):34-8. PubMed ID: 18220569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
